Testagen Clinical Trials Recruiting Now

Testagen trials recruiting now

1 registration that name testagen as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Trial Finder Not FDA-approved Read from ClinicalTrials.gov Oct 20, 2026 The Testagen peptide page

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Not yet recruitingNCT02733133

Product Transference Study of Testagen™ TDS®-Testosterone

Phase 2
Transdermal Delivery Solutions Corp
About 96 people
Starts Jan 5, 2027 (estimated)

In plain words A Phase 2 study of testagen in people 18 to 80, run by Transdermal Delivery Solutions Corp. It plans to enroll about 96 people and lists no sites yet.

Who it lists and where

Who the trial lists, as registered

Lists people 18 to 80; healthy volunteers accepted. Conditions: Hypogonadotropism.

Healthy Volunteers
Subject Couples, between 18 and 80 years of age, inclusive.
The subject couple is willing and able to read, understand the Subject Information Sheets and provide written informed consent.
The subject has a body mass index (BMI) within 18-30 kg/m2.

6 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Testagen® TDS Testosterone 5% HypoSpray®

Registered summary

This study will assess the potential of Testagen® TDS-Testosterone to enable transfer of Testosterone to females coming in contact with skin to which Testagen® TDS-Testosterone has been applied and the potential of product to raise serum androgen levels in those women.

Where, as registered

No sites listed yet.